- $24.00m
- $42.25m
- $37.16m
- 24
- 48
- 72
- 45
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.65 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -258.19% | ||
| Return on Equity | n/a | ||
| Operating Margin | -75.3% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | 14.23 | 24.34 | 37.16 | 38.54 | 75.1 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Marpai, Inc. is a technology-driven healthcare company, which uses artificial intelligence (AI) and data analytics. The Company provides administrative services and acts as a third-party administrator (TPA) to self-insured employers who provide healthcare benefits to their employees. Its products and services include Health Plan Administration services, Ancillary In-House services, and Third-Party Vendor services. Its Health Plan Administration services offering includes handling all aspects of administration related to a healthcare plan. Its In-House Ancillary Services are derived from its in-house products related to its role as the administrator of the clients' health plans. The Company typically design healthcare benefit plan for its client, which allows the client to define the coverage it would like to provide to its employees. The Company offers MarpaiRx, a national pharmacy benefit management program.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- January 22nd, 2021
- Public Since
- October 27th, 2021
- No. of Shareholders
- 38
- No. of Employees
- 162
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
NASDAQ Capital Market- Shares in Issue
- 10,300,548
- Address
- 615 Channelside Drive, Suite 207, TAMPA, 33602
- Web
- https://www.marpaihealth.com/
- Phone
- +1 6463033483
- Contact
- Steve Johnson
- Auditors
- UHY LLP
Upcoming Events for MRAI
Q1 2024 Marpai Inc Earnings Release
Q2 2024 Marpai Inc Earnings Release
Similar to MRAI
Abits
NASDAQ Capital Market
Ads-Tec Energy
NASDAQ Capital Market
AdTheorent Holding
NASDAQ Capital Market
Advanced Health Intelligence
NASDAQ Capital Market
AGM group
NASDAQ Capital Market
FAQ
What is the Marpai share price?
As of Today at 19:14 UTC, shares in Marpai are trading at $2.33. This share price information is delayed by 15 minutes.
How has the Marpai share price performed this year?
Shares in Marpai last closed at $2.33 and the price had moved by -35.49% over the past 365 days. In terms of relative price strength the Marpai share price has underperformed the S&P500 Index by -46.32% over the past year.
What are the analyst and broker recommendations for Marpai?
The overall consensus recommendation for Marpai is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Marpai dividend yield?
Marpai does not currently pay a dividend.
Does Marpai pay a dividend?
Marpai does not currently pay a dividend.
When does Marpai next pay dividends?
Marpai does not currently pay a dividend.
How do I buy Marpai shares?
To buy shares in Marpai you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Marpai?
As of the previous close price of $2.33, shares in Marpai had a market capitalisation of $24.00m.
Where are Marpai shares listed?
Here are the trading details for Marpai:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: MRAI
What kind of share is Marpai?
Based on an overall assessment of its quality, value and momentum Marpai is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Marpai share price forecast for 2024?
The analyst consensus target price for shares in Marpai is $6.00. That is 157.51% above the last closing price of $2.33.
Analysts covering Marpai currently have a consensus Earnings Per Share (EPS) forecast of -$1.47 for the next financial year.
What is the trend in the Marpai share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Marpai. Over the past six months, its share price has outperformed the S&P500 Index by +269.39%.
As of the last closing price of $2.33, shares in Marpai were trading +65.56% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Marpai PE Ratio?
The Marpai PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $2.33.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Marpai?
We do not have data on Marpai's directors